Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006-2009

Preventing Chronic Disease

Volumn 9, Issue 9, 2012, Pages

  Juarez, Deborah Taira ^a   Sentell, Tetine ^a   Tokumaru, Sheri ^b   Goo, Roy ^b   Davis, James W ^a   Mau, Marjorie M ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; INSURANCE; MALE; METABOLISM; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HAWAII; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84870403693     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd9.120065     Document Type: Article

References (30)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321(7258):405-12.
2. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329(5):304-9.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353(25):2643-53.
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352(9131):854-65.
6. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care 2008;31 (1):81-6.
7. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19(3):178-81.
8. Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care 2008;31(Suppl 2):150- 4.
9. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36(11):3008-13.
10. Chi A, Lissauer M, Kirchoffner J, Scalea T, Johnson S. Effect of glycemic state on hospital mortality in critically ill surgical patients. Am Surg 2011;77(11):1483-9.
11. Bruce DG, Davis WA, Davis TM. Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 2000;48(11):1449-53.
12. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom General Practice Research Database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006;28(3):388-95.
13. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health 2005;5:36-44.
14. Chiu C-J, Wray LA. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis 2010;7(1):A08 http://www.cdc.gov/pcd/issues/2010/jan/08_0250.htm Accessed December 9, 201
15. Blaum CS, Velez L, Hiss RG, Halter JB. Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997;20(1):7-11.
16. Ali MK, Bullard KM, Imperatore G, Barker L, Gregg EW. Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes - National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Morb Mortal Wkly Rep 2012;61(02):32-7.
17. Hartz A, Kent S, James P, Xu Y, Kelly M, Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2006;74(3):227-32.
18. Rose M, Fliege H, Hildebrandt M, Schirop T, Klapp BF. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care 2002;25(1):35-42.
19. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999;22(3):403-8.
20. Mayberry LS, Osborn C. Family support, medication adherence, and glyclemic control among adults with type 2 diabetes. Diabetes Care 2012;35(6):1239-45.
21. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care 2000;23(3):273-7.
22. Shani M, Taylor TR, Vinker S, Lustman A, Erez R, Elbayany A, et al. Characteristics of diabetics with poor glycemic control who achieve good control. J Am Board Fam Med 2008;21(6):490-6.
23. Clark DO, Von Korff MV, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995;33(8):783-95.
24. Plackett RL. Karl Pearson and the chi-squared test. Int Stat Rev 1983;51(1):59-72.
25. Holman R, Paul S, Bethel M, Matthews D, Neil H. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359(15):1577-89.
26. Farmer A, Gibson O, Neil A, Dudley C, Bryden K, Hayton PM, et al. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446). Diabetes Care 2005;28(11):2697-702.
27. Lane JT, Ferguson A, Hall J, McElligott M, Miller M, Lane PH, et al. Glycemic control over 3 years in a young adult clinic for patients with type 1 diabetes. Diabetes Res Clin Pract 2007;78(3):385-91.
28. Markowitz J, Laffel L. Transitions in care: support group for young adults with type 1 diabetes. Diabet Med 2012;29 (4):522-5.
29. Carter J, Gilliland S, Perez G, Skipper B, Gilliland F. Public health and clinical implications of high hemoglobin A1c levels and weight in younger adult Native American people with diabetes. Arch Intern Med 2000;160(22):3471.
30. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29 (8):1963-72.